• Sign In
  • Create Account
  • Orders
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • Orders
  • My Account

  • Sign out

  • Home
  • About Me
  • Press
  • P + P Shop
  • Blog
  • MORE
    • The Be Courageous Award
    • PDC Pharma Strategy
    • Contact
  • More
    • Home
    • About Me
    • Press
    • P + P Shop
    • Blog
    • MORE
      • The Be Courageous Award
      • PDC Pharma Strategy
      • Contact

Signed in as:

filler@godaddy.com

  • Home
  • About Me
  • Press
  • P + P Shop
  • Blog
  • MORE
    • The Be Courageous Award
    • PDC Pharma Strategy
    • Contact

Account

  • Orders
  • My Account

  • Sign out

  • Sign In
  • Orders
  • My Account

Press

Press Pitstops

I'm currently building my new press page so come back soon. More content is on the way!

Pitstops on Video

Does the pharma industry need to redefine the criteria for who can sponsor and execute clinical trials?

PDC Pharma Strategy CEO, Penelope Przekop, comments on this at the  FDA / Duke University-Margolis Institute for Health Policy public workshop, "Building Quality into the Design and Conduct of Clinical Studies: Integrating Quality by Design (QbD) and Risk-Based Monitoring (RBM) Approaches" on January 31st, 2024.  

learn more about pdc pharma strategy here

A conversation with Harsh Thakkar on Life Sciences 360: Building a Five-Star Career

Get the book

Talking about the science behind being the master of your destiny on GrasshoppHer

Get the book

A Conversation about 5-Star Career on The Chris Voss Show

Get the book

Subscribe to Join Team Penelope

Connect with Me

Copyright © 2023 Penelope Przekop, Author

Powered by

  • About Me
  • Press
  • P + P Shop
  • Blog
  • The Be Courageous Award
  • Contact
  • Product Sales Policies
  • FAQs - Bra in a Box

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept